Welcome
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 21,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
|
|
|
| NEWS | CONGRESSES |
|---|---|
|
July 27, 2010 Fresenius SE: First half of 2010: Preliminary Group net income substantially better than expected − Earnings outlook raised  PDF-Download (35 KBytes) 
June 10, 2010 Ketosteril Research Award - Solemn Award Ceremony at the XV International Congress on Nutrition and Metabolism in Renal Disease in Lausanne, Switzerland PDF-Download (128 KBytes)
May 04, 2010 Fresenius SE: Q1 2010: Successful start into 2010 − Outlook fully confirmed PDF-Download (142 KBytes)
|
September 05 - 08, 2010 You are warmly invited to visit us on our booth at ESPEN 2010, September 05. - 08., Nice, France click here
October 10 - 13, 2010 Come and visit us on our Fresenius Kabi booth at ESICM 2010; October 10. - 13., 2010, Barcelona, Spain click here
October 16 - 20, 2010 We are looking forward to welcome you on our booth at ASA 2010; October 16. - 20., 2010, San Diego, USA click here
|